Priscilla Hung Sells 750 Shares of Veeva Systems (NYSE:VEEV) Stock

Veeva Systems Inc. (NYSE:VEEV) Director Priscilla Hung sold 750 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the sale, the director directly owned 3,253 shares in the company, valued at $506,296.92. The trade was a 18.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Priscilla Hung also recently made the following trade(s):

• On Friday, April 10th, Priscilla Hung sold 750 shares of Veeva Systems stock. The shares were sold at an average price of $153.50, for a total transaction of $115,125.00.

Veeva Systems Stock Performance

VEEV stock opened at $171.44 on Wednesday. The firm has a 50 day moving average price of $174.52 and a 200-day moving average price of $215.44. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50. The firm has a market capitalization of $28.00 billion, a price-to-earnings ratio of 31.69, a PEG ratio of 0.76 and a beta of 0.92.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $835.95 million for the quarter, compared to the consensus estimate of $810.95 million. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.74 EPS. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, sell-side analysts forecast that Veeva Systems Inc. will post 6.41 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on VEEV shares. Barclays lowered their price target on Veeva Systems from $305.00 to $250.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. William Blair restated an “outperform” rating on shares of Veeva Systems in a research note on Tuesday, March 10th. Zacks Research raised shares of Veeva Systems from a “hold” rating to a “strong-buy” rating in a report on Wednesday, April 15th. Piper Sandler dropped their target price on shares of Veeva Systems from $355.00 to $285.00 and set an “overweight” rating on the stock in a research note on Thursday, March 5th. Finally, Wall Street Zen cut shares of Veeva Systems from a “buy” rating to a “hold” rating in a report on Sunday, March 22nd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $278.70.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. GPS Wealth Strategies Group LLC boosted its holdings in Veeva Systems by 196.4% in the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock worth $25,000 after purchasing an additional 55 shares during the last quarter. SHP Wealth Management bought a new stake in Veeva Systems in the 4th quarter worth approximately $26,000. Board of the Pension Protection Fund purchased a new stake in Veeva Systems during the 4th quarter valued at $27,000. Raiffeisen Bank International AG bought a new position in shares of Veeva Systems during the 3rd quarter valued at $28,000. Finally, Newbridge Financial Services Group Inc. lifted its holdings in shares of Veeva Systems by 322.6% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 100 shares during the period. 88.20% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: S&P 500 inclusion + management change — Veeva’s announced addition to the S&P 500 (effective May 7) and a reported general counsel transition sparked index-driven buying and a volume gap-up as ETFs and passive funds adjust holdings. Veeva Systems (VEEV) Is Up 6.9% After S&P 500 Addition and GC Transition News
• Positive Sentiment: GenAI / industry positioning — multiple industry write-ups flag Veeva as a beneficiary of rising GenAI adoption in healthcare workflows, supporting the growth narrative for its Vault platform and CRM suites. This thematic coverage attracts software-focused investors. Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell
• Positive Sentiment: Solid fundamentals and capital return — recent quarterly results showed an earnings beat and double-digit revenue growth; plus a $2.0B buyback program remains in place, which can support shares over time as buybacks reduce float. Veeva Systems Stock Page
• Neutral Sentiment: Brokerage coverage / analyst consensus — media pieces highlighting average broker recommendations and “Moderate Buy” consensus can amplify momentum but are not new fundamentals; analyst price targets remain wide. Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
• Neutral Sentiment: Repeat thematic coverage — additional Zacks / industry write-ups reiterate the GenAI tailwind; useful for sentiment but largely confirmatory rather than new catalysts. 3 Medical Info Systems Stocks Riding the GenAI Wave
• Negative Sentiment: Insider selling disclosed — Director Priscilla Hung sold 750 shares under a pre-arranged Rule 10b5?1 plan. While routine, the sale can trigger short-term concern among some investors about insider conviction. Insider Selling: Veeva Systems Director Priscilla Hung Sells 750 Shares

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.